Somatostatin Other names: Growth hormone-inhibiting hormone Somatotropin release-inhibiting factor SRIF GHIH

Molecular mass: 1,637.9 g/mol  PubChem compound: 16129681

Therapeutic indications

Somatostatin is indicated for:

Indication

Population group: only adults (18 years old or older)

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Somatostatin is contraindicated in the following cases:

Contraindication

at least one of
Unspecified adverse effect of drug or medicament
Lactation
Pregnancy
Glucose
Fructose

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈